MarketScreener Strategies Galapagos NV Euronext Bruxelles
Equities
GLPG
BE0003818359
End-of-day quote
Other stock markets
|
||
- | - |
31/05 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
31/05 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
- Stock Market
- Equities
- GLPG Stock
- GLPG Stock
- News Galapagos NV
- MarketScreener Strategies